A ROBOT-ASSISTED PERFUSION SYSTEM TO IMPROVE PATIENT SAFETY IN THE CARDIAC OPERATING ROOM
机器人辅助灌注系统可提高心脏手术室患者的安全
基本信息
- 批准号:10442068
- 负责人:
- 金额:$ 76.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:AdoptedAdultAdverse eventAlgorithmsAnesthesia proceduresArtificial IntelligenceAwarenessBeliefCardiacCardiac Surgery proceduresCardiopulmonary BypassChildhoodClinicalClinical Decision Support SystemsCognitionCognitiveCommunicationComplexComputersCuesCustomDataDecision MakingDecision Support SystemsDeteriorationDiscipline of NursingElectrocardiogramElectroencephalographyEngineeringEnsureEnvironmentExpert SystemsFatigueFutureGoalsGoldHealth PersonnelHeterogeneityHospitalsHourHumanImpairmentIncidenceInterruptionIntuitionKnowledgeLaboratoriesLeadLearningLibrariesLiteratureMeasuresMedicalMedical ErrorsModelingNursesOperating RoomsOperative Surgical ProceduresOutcomePatient CarePatientsPerformancePerfusionPerioperative NursingPhasePhysiologicalPoliciesProbabilityProceduresProcessProtocols documentationProviderReportingRewardsRiskRobotRoboticsSafetySerious Adverse EventStandardizationStressSystemTechniquesTechnologyTimeTrainingTrustUncertaintyVariantVentilatorWorkWorkloadapprenticeshipbasebiomarker performanceclinical practicecognitive loadcomputational intelligencedesigndigitaldistractionexperiencehuman errorhuman-in-the-loopimprovedinteroperabilityknowledge basemedical schoolsnovelopen sourceoperationpatient safetypreventrobot assistancesimulationskillsstandardized careusabilityvirtual surgeryvisual trackingwillingness
项目摘要
PROJECT SUMMARY / ABSTRACT
The vast majority of pediatric and adult cardiac surgery procedures worldwide involve the use of
cardiopulmonary bypass with a dedicated and highly customized perfusion system. Cardiac surgery
procedures are complex and entail safety-critical activities, requiring continuous coordination between four
subteams: perfusion, surgical, nursing and anesthesia. This environment demands outstanding technical and
non-technical skills (e.g. teamwork, communication and situational awareness).
Over the past few decades, technological advancements have improved the safety and efficiency of the
perfusion system, however, despite substantial progress, recent studies continue to report a high incidence of
preventable intraoperative adverse events among cardiac surgery patients. The perfusion system, in particular,
relies heavily on the expertise and skills of the perfusionist, and there is currently no computational intelligent
system to support perfusionists' optimal decision-making during the critical phase of cardiopulmonary bypass.
In this proposal, we seek to develop a data-driven approach to learn from expert perfusionists how to achieve
optimal outcomes for cardiac surgery patients. Rather than attempt to engineer a solution, we propose to
develop a computer-based apprentice that can learn from high-quality demonstrations of perfusionist actions to
infer gold-standard patient care. Our goal is to develop and evaluate a Robot-Assisted Perfusion System
(RAPS) that can be integrated into the cardiac surgery workflow as a non-human teammate. The RAPS will
support the perfusion team in a way that perfusionists still will keep control of the perfusion system (i.e. human-
in-the-loop), but cognitively supported and guided by the RAPS.
项目摘要 /摘要
全世界的绝大多数儿科和成人心脏手术程序都涉及使用
具有专用且高度定制的灌注系统的心肺旁路。心脏手术
程序是复杂的,需要安全至关重要的活动,需要四个
子程度:灌注,手术,护理和麻醉。这个环境需要出色的技术和
非技术技能(例如团队合作,沟通和情境意识)。
在过去的几十年中,技术进步提高了
然而,尽管取得了长足的进展,但最近的研究仍报告很高的发病率
心脏手术患者中可预防的术中不良事件。尤其是灌注系统
在很大程度上依赖灌注者的专业知识和技能,目前尚无计算智能
在心肺旁路的关键阶段支持灌注者最佳决策的系统。
在此提案中,我们试图开发一种以数据为基础的方法,向专家灌注者学习如何实现
心脏手术患者的最佳结局。而不是试图设计解决方案,我们建议
开发一个基于计算机的学徒,可以从灌注主义行为的高质量演示中学习到
推断金标准的患者护理。我们的目标是开发和评估机器人辅助的灌注系统
(RAP)可以作为非人类队友整合到心脏手术工作流程中。说唱会
支持灌注团队以灌注者仍将控制灌注系统的方式(即人类)
在循环中),但认知支持和指导着说唱。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Roger Daglius Dias其他文献
Roger Daglius Dias的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Roger Daglius Dias', 18)}}的其他基金
A ROBOT-ASSISTED PERFUSION SYSTEM TO IMPROVE PATIENT SAFETY IN THE CARDIAC OPERATING ROOM
机器人辅助灌注系统可提高心脏手术室患者的安全
- 批准号:
10668333 - 财政年份:2022
- 资助金额:
$ 76.49万 - 项目类别:
A ROBOT-ASSISTED PERFUSION SYSTEM TO IMPROVE PATIENT SAFETY IN THE CARDIAC OPERATING ROOM
机器人辅助灌注系统可提高心脏手术室患者的安全
- 批准号:
10184079 - 财政年份:2021
- 资助金额:
$ 76.49万 - 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Teratogenicity assessment of new antiviral drugs using 3D morphogenesis models
使用 3D 形态发生模型评估新型抗病毒药物的致畸性
- 批准号:
10741474 - 财政年份:2023
- 资助金额:
$ 76.49万 - 项目类别:
Predicting and Preventing Adverse Maternal and Child Outcomes of Opioid Use Disorder in Pregnancy
预测和预防妊娠期阿片类药物使用障碍的不良母婴结局
- 批准号:
10683849 - 财政年份:2023
- 资助金额:
$ 76.49万 - 项目类别:
Drug Eluting Silk Fibroin Grafts for Repair of Long Urethral Strictures
药物洗脱丝素蛋白移植物修复长尿道狭窄
- 批准号:
10587176 - 财政年份:2023
- 资助金额:
$ 76.49万 - 项目类别:
A non-viral CRISPR-mediated genome editing delivery platform as a potential therapy for neurogenetic diseases
非病毒 CRISPR 介导的基因组编辑传递平台作为神经遗传疾病的潜在疗法
- 批准号:
10739113 - 财政年份:2023
- 资助金额:
$ 76.49万 - 项目类别:
BPCA INNOVATIVE TRIAL DESIGNS AND ASSAY DEVELOPMENTS IN PEDIATRIC THERAPEUTICS
BPCA 儿科治疗的创新试验设计和检测开发
- 批准号:
10936040 - 财政年份:2023
- 资助金额:
$ 76.49万 - 项目类别: